pharma news today obesity drug glp-1 Drugmaker Eli Lilly announced that the FDA approved its daily pill, which will be marketed under the name Foundayo, to treat obesity. ABC News' Youri Benadjaoud reports. https://abcnewslive.visitlink.me/pYGbNh Eli Lilly obesity pill Foundayo

However, only ~ 50% patients with opioid-induced constipation exhibit satisfactory response to PAMORA-based clinical management strategies targeting MORs in the enteric nervous system, and we observed that naloxegol could only partially alleviate morphine-induced constipation

People who lack vitamin B12 seek to understand how long it takes for the vitamin B12 to begin working

But 'very weak' isn't 'zero.' At very high, supra-physiological doses not typically used in responsible research, some minor, transient elevations might be observed

hsCRP is associated with an increased risk of cardiovascular disease as well, so what about lipids